Diversity Evolution

The United States is becoming more diverse. Is the medical education system adapting quickly enough? The need for increased diversity in the medical profession is not breaking news. In 2004, the Institute of Medicine (IOM)...

Online Exclusives

MSC-100-IV Receives Fast-Track Designation

The U.S. Food and Drug Administration has granted fast-track designation for MSC-100-IV for pediatric patients with steroid-refractory acute graft-versus-host disease (aGVHD) following allogeneic hematopoietic...

Mortality Rates in Childhood Cancer Higher Than Previously Thought

Early death among young children (<1 year of age) with cancer is higher than previous estimates according to a study published in the Journal...

News

From the Blood Journals

Choosing Between Strategies for Managing Fetal or Neonatal Alloimmune Thrombocytopenia

For women diagnosed with fetal and neonatal alloimmune thrombocytopenia (FNAIT), a noninvasive strategy of weekly intravenous immunoglobulin infusion (IVIg) and corticosteroids could help prevent...

Self-Reporting Significantly Overestimates Treatment Adherence in Pediatric Patients With Acute ...

Maintenance therapy with oral 6-mercaptopurine (6MP) for pediatric patients with acute lymphocytic leukemia (ALL) is crucial for maintaining a durable remission, and poor adherence...

Latest Videos

video

Stephen M. Ansell, MD, PhD: Nivolumab Moves to Hematology

Dr. Ansell, a speaker in the Special Education Session on Newly Approved Drugs, discusses the growing role of nivolumab in hematologic malignancies.
video

Eugenia Vicky Asare, MD: Multidisciplinary Care Saves Lives Among Pregnant Women...

Dr. Asare shares how instituting simple protocols and a multidisciplinary approach dramatically reduced the mortality rate of pregnant women with sickle cell disease living...
video

ASP2215 Successfully Inhibits FLT3 in High-Risk AML Patients

Mark J. Levis, MD, PhD, discusses the results of a phase I/II trial of ASP2215, which was shown to potently, selectively, and sustainably inhibit...
video

Ruxolitinib in CMML: Study Shows Promising Results

Eric Padron, MD, shares results from the phase I study of ruxolitinib in chronic myelomonocytic leukemia, a rare type of myelodysplastic, myeloproliferative neoplasm with...

On Location

Early Studies Reveal Efficacy, Safety Concerns With Vadastuximab Talirine in Patients With Acute Myeloid Leukemia

Early studies of vadastuximab talirine (33A) in patients with acute myeloid leukemia (AML) have shown...

Phase I Study Shows Venetoclax Active in Patients With Relapsed/Refractory Myeloma

The B-cell lymphoma/leukemia-2 (BCL-2) inhibitor venetoclax may be a new option for patients with heavily...

Newly Approved Drugs: How to Use Them in Practice

In 2016, the U.S. Food and Drug Administration (FDA) approved several new therapies for the...

BLU-285 Shows Tolerable Safety, Early Clinical Activity in Patients With Advanced Systemic Mastocytosis

BLU-285, an oral inhibitor of KIT D816V, is well tolerated and could alleviate symptom burden...

Double Hematopoietic Cell Transplantation Extends Progression-Free Survival Over Single Transplant in Myeloma Patients

Following bortezomib-based induction therapy, patients with newly diagnosed multiple myeloma (MM) who received double autologous...

Does the Addition of ATLG Improve Outcomes After Allogeneic Transplantation?

Previous studies have suggested that adding anti-T lymphocyte globulin (ATLG) to the treatment regimen for...

Latest Headlines

Advertisement

ASH Directions

The ASH Bridge Grant Program, Announcing the 2017 TRTH Program Participants, and more

Thursday, July 21st, 2016
Apply for the ASH Bridge Grant Program ASH is accepting applications for the Bridge Grant Program through May 1, 2017. The program was created to...

March 2017: ASH Joins Medical Groups in Expressing Concern Over Immigration Executive Order, and...

Thursday, July 21st, 2016
ASH Joins Medical Groups in Expressing Concern Over Immigration Executive Order President Donald Trump’s executive order of January 27, which suspended “issuance of visas and...

Sign up for our e-Newsletter!

Richard Pazdur Named Director of Oncology Center of Excellence, Be The Match Foundation® Receives...

Thursday, July 21st, 2016
Stephen Gottschalk Joins St. Jude Children’s Research Hospital Stephen Gottschalk, MD, was named chair of the Department of Bone Marrow Transplantation and Cellular Therapy at...

Remembering Peter C. Nowell, MD, Niels Borregaard, MD, PhD, Laurence Boxer, MD, and more

Thursday, July 21st, 2016
Peter C. Nowell, MD (1928-2016) Peter C. Nowell, MD, an acclaimed researcher and co-discoverer of the Philadelphia chromosome, which pointed for the first time to...

ASH Recognizes Choosing Wisely® Champions, NIH Awards Grant to Examine Spliceosomal Mutations in MDS,...

Thursday, July 21st, 2016
ASH Recognizes Choosing Wisely® Champions During Annual Meeting The American Society of Hematology (ASH) recognized three inaugural Choosing Wisely® Champions during the 2016 annual meeting....

Diversity Evolution

Thursday, July 21st, 2016
The United States is becoming more diverse. Is the medical education system adapting quickly enough? The need for increased diversity in the medical profession is...

Affordable Care Act: Exit, Stage Right

Thursday, July 21st, 2016
The rollback of the Affordable Care Act (ACA) is underway. Within hours of taking the oath of office on January 20, President Donald Trump...

Cartwheels for CAR T-Cell Therapy?

Thursday, July 21st, 2016
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary approach to targeted immunotherapy to treat cancer, and the details can seem like the stuff...